Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition
NCT01503437
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Fasting
Interventions
DRUG:
Olanzapine OD Tablets 5 mg
Sponsor
Dr. Reddy's Laboratories Limited